EXACT Sciences Corporation (EXAS) Annual Income Statement (USD)
EXAS Quarterly Financials (USD)
Frequently Asked Questions About EXACT Sciences Corporation (EXAS) Stock
EXACT Sciences Corporation's (EXAS) last reported annual revenue was USD 2.50 Billion.
EXACT Sciences Corporation's (EXAS) annual revenue growth rate based on the revenue reported in the past 5 years is : 40.63%
EXACT Sciences Corporation's(EXAS) is not profitable as of its last reported annual financials.
The net profit margin for EXACT Sciences Corporation's(EXAS) from its laster reported year is -8.17%
The return on equity (ROE) for EXACT Sciences Corporation's(EXAS) from its last reported annual financials is : -6.76%
The return on assets (ROA) for EXACT Sciences Corporation's(EXAS) from its last reported annual financials is : -2.16%
The return on invested capital (ROIC) for EXACT Sciences Corporation's(EXAS) from its last reported annual financials is : -4.05%
The Debt to Equity ratio for EXACT Sciences Corporation's(EXAS) from its last reported annual financials is : 73.58%
The dividend yield for EXACT Sciences Corporation's(EXAS) from its laster reported year is 0.00%
EXACT Sciences Corporation's(EXAS) has negative cash flow as of its last reported annual financials.
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
Positive cash flow
The company had positive total cash flow in the most recent four quarters.
Positive free cash flow
The company had positive total free cash flow in the most recent four quarters.
High market capitalization
This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.
Superior Revenue Growth
This stock has shown top quartile revenue growth in the previous 5 years compared to its sector.
Superior Earnings Growth
This stock has shown top quartile earnings growth in the previous 5 years compared to its sector.
What not to like
Overpriced compared to book value
The stock is trading high compared to its peers median on a price to book value basis.
Overpriced on cashflow basis
The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.
Low Dividend Growth
This stock has shown below median dividend growth in the previous 5 years compared to its sector.
Highly leveraged
The company is in the bottom half compared to its sector peers on debt to equity and is highly leveraged. However, do check the news and look at its sector and management statements. Sometimes this is high because the company is trying to grow aggressively.
Overpriced on free cash flow basis
The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for EXAS !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
